Alnylam Pharmaceuticals
ALNY
#555
Rank
A$61.19 B
Marketcap
A$461.44
Share price
-3.01%
Change (1 day)
9.35%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company